Are you equipped to treat the 'new menopause patient'?
Industry Buzz
“This is the ‘Super-Mom’ generation, who want to ace every aspect of their life, whether it's work or family. This quest for perfection takes a toll on our body by ‘burning’ our adrenals… The medical professionals they approach are not trained in taking care of [their] symptoms." — Meena Malhotra, MD, internal medicine and obesity medicine practitioner
"My old doctor just looked baffled about my symptoms. ‘You're too young for menopause. You're depressed; here's some Prozac'... We're sick and tired of not being heard, or helped.” — Patient, Reddit user @suminorieh77
Gen X women (born 1965–1980) reject the old “suffer in silence” model of menopause. Are you equipped to treat them?
As one commentator (@suminorieh77) put it on Reddit: “Our mothers and grandmothers were silent about all of this. it was taboo to speak about such things, to prepare their offspring for the next phase.”[]
Many report frustration toward medical providers who dismiss their symptoms, a practice increasingly challenged by this cohort.
In her comment, user @suminorieh77 described her experience: “[Perimenopause] hit me at 43 (45 now). everything is crazy. my old doctor just looked baffled about my symptoms. ‘You're too young for menopause. You're depressed; here's some Prozac.’ never even heard the term 'perimenopause' before...new doc ran tests, confirmed that i'm indeed in peri. i'm grateful she listens and is trying to help me…so, yeah, we're sick and tired of not being heard, or helped.”
The 'Super-Mom' generation
Meena Malhotra, MD, an internal medicine and obesity medicine practitioner, confirms these issues. “Gen X women are known for their independence,” she tells MDLinx. “This is the ‘Super-mom’ generation, who want to ace every aspect of their life whether it's work or family. This quest for perfection takes a toll on our body by ‘burning’ our adrenals… [Some of] the medical professionals whom they approach are not trained in taking care of perimenopausal and menopausal symptoms, and the misinformation from the Women's Health Initiative study is rampant,” she says.
Related: Many physicians still consider VMS to be transient and inconsequential, but new research suggests otherwise—are you all caught up?High expectations for providers
A poll of 2,000 US women by Talker Research revealed 60% resort to self-learning about perimenopause and menopause as their providers didn’t inform them.[] Gen X respondents reported feeling relatively confident in their knowledge, but overall preparation was lacking. Only 25% of the women surveyed felt well-educated by their healthcare provider.
These patients expect up-to-date, empathetic care. They're less tolerant of offhand explanations like, “It’s just aging,” demanding instead a clinical approach informed by current evidence and tailored to their needs.
“I start by validating their experience, as no one should feel ignored, says Sameea Chughtai, MD, a board-certified physician. “I take a detailed history, review prior evaluations, and discuss all available treatment options so they feel heard and empowered to make decisions about their care.”
Menopause disrupts work and well-being
Menopausal symptoms cause significant workplace impact: a Mayo Clinic study estimates a staggering $1.8 billion lost annually in the US due to missed workdays from these symptoms.[]
Carrot Fertility’s Menopause in the Workplace 2023 report found that 80% of surveyed women in the US and UK view menopause as a challenge in the workplace, and over half have thought about changing jobs due to its impact.[]
Providers should recognize that symptoms like brain fog, mood swings, sexual concerns, or hot flashes are not just minor irritations. They’re often disruptive to work, relationships, and quality of life. “Menopause can impact productivity, confidence, intimacy, and mood. Addressing these topics openly helps normalize the experience and allows us to discuss coping strategies,” says Dr. Chughtai.
Gen X in the clinic
Menopause symptom management has evolved well beyond traditional menopausal hormone therapy, though it remains the most effective option for vasomotor symptoms, mood disturbances, and genitourinary syndrome of menopause (GSM) when started before age 60 or within 10 years of menopause onset. Low-dose vaginal estrogen, often underused, effectively treats GSM without increasing breast cancer risk.
Nonhormonal pharmacologic options are rapidly advancing. One such option is fezolinetant (Veozah), an FDA- and EU-approved NK3₃ receptor antagonist, that significantly reduces hot flash frequency and severity and improves quality of life, though liver function monitoring is required.
Another option some clinicians discuss is bioidentical hormone replacement therapy (BHRT). BHRT uses hormones that are chemically identical to those produced by the human body, often derived from plant sources like yams or soy.
According to Dr. Malhotra, “BHRT not only provides relief from these symptoms but enhances quality of life and can even shield from chronic disease. Women deserve to be listened to with empathy and educated with unbiased data so they can make informed decisions for themselves.”
Generation X women are reshaping the menopause conversation. Providers must adapt to this shift, or risk being perceived as outdated.